Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01734122|
Recruitment Status : Recruiting
First Posted : November 27, 2012
Last Update Posted : November 1, 2016
|Condition or disease|
|Tremor Essential Tremor Parkinson Disease Radiosurgery Quality of Life|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||30 participants|
|Official Title:||Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor|
|Study Start Date :||November 2012|
|Estimated Primary Completion Date :||November 2017|
|Estimated Study Completion Date :||November 2018|
- Quality of Life [ Time Frame: 1 year ]The tremor-related quality of life for each patient will be assessed by self-assessment questionnaire at 3 month intervals for 1 year after treatment by stereotactic radiation.
- Severity of Tremor [ Time Frame: 1 year ]The severity of tremor will be assessed by objective measure (Fahn-Tolosa-Marin tremor rating scale) at 3 month intervals for 1 year following the stereotactic radiation treatment.
- Neuropsychological Assessment [ Time Frame: Baseline and 6 months post-treatment ]All patients will undergo a neuropsychological assessment (1-2 hr examination) at baseline and at 6 months post-treatment. This will assess any unanticipated changes in neuropsychological brain function.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01734122
|United States, Tennessee|
|Vanderbilt University Medical Center||Recruiting|
|Nashville, Tennessee, United States, 37232|
|Contact: Send Patient Referrals to Movement Disorder Coordinators 615-322-0141 ext Fax 6153436847|
|Contact: Vanderbilt University Radiation Oncology (nursing staff) 615-343-2624|
|Principal Investigator: Austin N. Kirschner, MD, PhD|
|Principal Investigator: Anthony J. Cmelak, MD|
|Sub-Investigator: Joseph S. Neimat, MD|
|Sub-Investigator: Fenna T. Phibbs, MD, MPH|
|Sub-Investigator: Peter Hedera, MD|
|Sub-Investigator: Scott A Wylie, PhD|
|Sub-Investigator: Hong Yu, MD|